Document is current
Any future updates will be listed below
-
Authors
Sondak, Vernon K.
Messina, Jane L.
- License Information
-
More Information
Article History
Accepted: 1 May 2024
First Online: 23 May 2024
Declarations
:
: The authors declare no competing interests.
: This work had no specific funding.Disclosures outside the scope of this work: Dr Sondak reports personal consulting fees from Bristol Myers Squibb, Genesis Drug Discovery & Development, Iovance, Merck, Mural Oncology, Novartis, and Sun Pharmacetuicals, and receives research funding from Neogene Therapeutics, Skyline and Turnstone. Dr Messina reports nothing to disclose.
